Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">TrovaGene downgraded to Hold at Maxim Group (1.75)Maxim Group downgrades TROV to Hold from Buy after reported essentially burning just under $10M in the quarter and ending the year with $38M in cash. Firm's current model is focused on Trovagene the diagnostics company and we will need to re-evaluate the company given the new focus on developing diagnostic-based therapeutics. As such, for the moment they are lowering rating to Hold while they evaluate the new strategic direction.</td> </tr></table>"